Universal-Beteiligungs- und Servicegesellschaft’s Rhythm Pharmaceuticals RYTM Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio RYTM Stock Details RYTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.04M	Sell	9,393 -53,543	-85%	-$4.84M	﹤0.01%	1541
2026 Q1	$5.47M	Sell	62,936 -60,601	-49%	-$5.89M	0.01%	833
2025 Q4	$13.2M	Buy	123,537 +22,165	+22%	+$2.35M	0.02%	508
2025 Q3	$10.2M	Buy	101,372 +5,855	+6%	+$544K	0.02%	591
2025 Q2	$6.04M	Buy	95,517 +2,412	+3%	+$148K	0.01%	751
2025 Q1	$4.93M	Buy	93,105 +17,021	+22%	+$944K	0.01%	806
2024 Q4	$4.26M	Buy	+76,084	New	+$4.2M	0.01%	752

Other funds holding RYTM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's RYTM Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its Rhythm Pharmaceuticals (RYTM) stake by 85% in Q2 2026, selling an estimated $4.84M and leaving 9,393 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #1541.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in RYTM in Q4 2024 and has held it in 7 quarters since. The position peaked at $13.2M in Q4 2025. 151 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

Universal-Beteiligungs- und Servicegesellschaft held 9,393 shares of Rhythm Pharmaceuticals worth $1.04M as of Q2 2026.
Universal-Beteiligungs- und Servicegesellschaft sold 53,543 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $4.84M.
Rhythm Pharmaceuticals made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #1541 holding.
Universal-Beteiligungs- und Servicegesellschaft first reported a position in Rhythm Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
Universal-Beteiligungs- und Servicegesellschaft's Rhythm Pharmaceuticals position peaked at $13.2M in Q4 2025.
151 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.